Early Innate Immune Activation Linked to Ad26.COV2.S Vaccine Effectiveness
A study using RNA sequencing and proteomic profiling found that innate immune activation within the first day after Ad26.COV2.S (Johnson & Johnson) vaccination correlates with stronger long-term immune responses and lower viral loads after SARS-CoV-2 challenge. The research was conducted in 25 rhesus macaques and validated in a cohort of 25 healthy adult humans. These findings suggest early innate immune signatures could serve as predictive biomarkers for vaccine efficacy.
Researchers performed bulk RNA sequencing and proteomic profiling in 25 rhesus macaques following immunization with Ad26.COV2.S, the Johnson & Johnson single-dose COVID-19 vaccine, to identify early innate immune correlates of vaccine performance. Innate immune activation was detectable as early as day 1 post-vaccination, characterized by systemic enrichment of antiviral interferon pathways, interleukin signaling, and innate immune cell signatures. These transcriptomic signatures at the earliest timepoints correlated positively with both humoral (antibody) and cellular immune responses measured at six weeks post-vaccination. Critically, the same early signatures correlated inversely with viral loads following subsequent SARS-CoV-2 challenge, suggesting they are predictive of actual protective efficacy. Parallel analysis in a cohort of 25 healthy adult human volunteers vaccinated with Ad26.COV2.S revealed similar correlates of immunogenicity, lending translational relevance to the animal model findings. The study underscores the importance of the innate immune system in shaping the quality and durability of vaccine-induced adaptive immunity.
What's missing
The study has several notable limitations: it is unclear whether these innate immune correlates generalize to other vaccine platforms beyond adenoviral vectors. The study also does not address whether these signatures differ by age, sex, or pre-existing immunity, and the Ad26.COV2.S vaccine has since been withdrawn from most markets, raising questions about the broader applicability of these findings.
What different sources said
- bioRxivCenter
Early innate immune signatures correlate with Ad26.COV2.S vaccine durability and protective efficacy
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.